Skip to main content

Table 1 The characteristics of RA patients according to the serum klotho concentration

From: A prospective study of the association between serum klotho and mortality among adults with rheumatoid arthritis in the USA

Characteristics

Total

Serum klotho

Q1

Q2

Q3

Q4

p value

N = 841

N = 211

N = 209

N = 210

N = 211

Gender (%)

     

0.024

 Male

354 (42.09)

97 (45.97)

95 (45.45)

92 (43.81)

70 (33.18)

 

 Female

487 (57.91)

114 (54.03)

114 (54.55)

118 (56.19)

141 (66.82)

 

Age, years (%)

     

0.358

  < 60

355 (42.21)

86 (40.76)

86 (41.15)

83 (39.52)

100 (47.39)

 

  ≥ 60

486 (57.79)

125 (59.24)

123 (58.85)

127 (60.48)

111 (52.61)

 

Race (%)

     

0.170

 Non-Hispanic White

332 (39.48)

82 (38.86)

92 (44.02)

92 (43.81)

66 (31.28)

 

 Non-Hispanic Black

251 (29.84)

64 (30.33)

56 (26.79)

53 (25.24)

78 (36.97)

 

 Mexican American

128 (15.22)

31 (14.69)

34 (16.27)

31 (14.76)

32 (15.17)

 

 Others

130 (15.46)

34 (16.11)

27 (12.92)

34 (16.19)

35 (16.59)

 

Education level (%)

     

0.092

 Less than 9th grade

130 (15.46)

34 (16.11)

30 (14.35)

30 (14.29)

36 (17.06)

 

 9–11th grade

155 (18.43)

52 (24.64)

37 (17.70)

29 (13.81)

37 (17.54)

 

 High school graduate

189 (22.47)

41 (19.43)

50 (23.92)

60 (28.57)

38 (18.01)

 

 Some college or AA degree

265 (31.51)

64 (30.33)

66 (31.58)

69 (32.86)

66 (31.28)

 

 College graduate or above

102 (12.13)

20 (9.48)

26 (12.44)

22 (10.48)

34 (16.11)

 

Marital status (%)

     

0.044

 Married or living with partner

480 (57.07)

120 (56.87)

134 (64.11)

124 (59.05)

102 (48.34)

 

 Widowed, divorced, or separated

293 (34.84)

73 (34.60)

60 (28.71)

74 (35.24)

86 (40.76)

 

 Never married

68 (8.09)

18 (8.53)

15 (7.18)

12 (5.71)

23 (10.90)

 

Family poverty income ratio (%)

     

0.526

 0.00–1.00

239 (28.42)

63 (29.86)

57 (27.27)

60 (28.57)

59 (27.96)

 

 1.00–3.00

375 (44.59)

103 (48.82)

90 (43.06)

88 (41.90)

94 (44.55)

 

  ≥ 3.00

227 (26.99)

45 (21.33)

62 (29.67)

62 (29.52)

58 (27.49)

 

BMI, kg/m2 (%)

     

0.422

  < 25.0

158 (18.79)

37 (17.54)

40 (19.14)

39 (18.57)

42 (19.91)

 

 25.0–30.0

238 (28.30)

58 (27.49)

66 (31.58)

66 (31.43)

48 (22.75)

 

  ≥ 30.0

445 (52.91)

116 (54.98)

103 (49.28)

105 (50.00)

121 (57.35)

 

Ever drinking (%)

     

0.054

 Yes

566 (67.30)

153 (72.51)

142 (67.94)

144 (68.57)

127 (60.19)

 

 No

275 (32.70)

58 (27.49)

67 (32.06)

66 (31.43)

84 (39.81)

 

Cotinine, ng/ml

0.07 (0.02,92.10)

0.13 (0.02,129.00)

0.09 (0.02,163.00)

0.07 (0.02,19.30)

0.05 (0.02,1.06)

0.303

Hypertension (%)

     

0.714

 Yes

541 (64.33)

142 (67.30)

131 (62.68)

136 (64.76)

132 (62.56)

 

 No

300 (35.67)

69 (32.70)

78 (37.32)

74 (35.24)

79 (37.44)

 

Diabetes (%)

     

0.661

 Yes

239 (28.42)

54 (25.59)

58 (27.75)

62 (29.52)

65 (30.81)

 

 No

602 (71.58)

157 (74.41)

151 (72.25)

148 (70.48)

146 (69.19)

 

eGFR, mL/(min × 1.73 m2) (%)

     

0.013

  < 60.0

119 (14.15)

43 (20.38)

29 (13.88)

27 (12.86)

20 (9.48)

 

  ≥ 60.0

722 (85.85)

168 (79.62)

180 (86.12)

183 (87.14)

191 (90.52)

 

Physical activity, MET time/week (%)

     

0.976

  < 600

446 (53.03)

114 (54.03)

106 (50.72)

113 (53.81)

113 (53.55)

 

 600–1200

87 (10.34)

22 (10.43)

20 (9.57)

23 (10.95)

22 (10.43)

 

  ≥ 1200

308 (36.63)

75 (35.55)

83 (39.71)

74 (35.24)

76 (36.02)

 

25-hydroxyvitamin D, nmol/L (%)

     

0.780

  < 50.0

271 (32.22)

148 (70.14)

142 (67.94)

142 (67.62)

138 (65.40)

 

  ≥ 50.0

570 (67.78)

63 (29.86)

67 (32.06)

68 (32.38)

73 (34.60)

 

NHANES cycles (%)

     

0.006

 2007–2008

199 (23.67)

55 (26.07)

42 (20.10)

53 (25.24)

49 (23.22)

 

 2009–2010

180 (21.40)

51 (24.17)

54 (25.84)

38 (18.10)

37 (17.54)

 

 2011–2012

143 (17.00)

24 (11.37)

33 (15.79)

47 (22.38)

39 (18.48)

 

 2013–2014

146 (17.36)

26 (12.32)

38 (18.18)

43 (20.48)

39 (18.48)

 

 2015–2016

173 (20.57)

55 (26.07)

42 (20.10)

29 (13.81)

47 (22.27)

 
  1. BMI body mass index, CI confidence interval, eGFR estimated glomerular filtration rate, HR hazard ratio, PIR poverty income ratio